Search & Filter

The first fixed-combination, cutaneous foam spray for the once-daily topical treatment of all extents of plaque psoriasis for patients who are 18 years or older has been launched in the UK.

The national annual percentage of women recorded as smokers at the time of giving birth has fallen below the national target €“ and the lowest since records began in 2006 €“ according to new figures published today.

Over 260,000 people with atrial fibrillation (AF) could be at risk of stroke as they are receiving either no preventative treatment or are still taking only aspirin, no longer recommended by NICE for the prevention of AF-related stroke.

Patients with psoriatic arthritis (PsA) could one day benefit from a new drug, following results posted from a phase 1B study that evaluated the pharmacokinetics, safety, tolerability and preliminary efficacy of multiple doses of the drug.

New research into Peyronie's disease has revealed the devastating mental toll on those affected, and their struggle to receive proper treatment and support.

The GLP-1 receptor analogue liraglutide (Victoza) significantly reduced the risk of the composite primary endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (heart attack) or non-fatal stroke by 13% versus placebo.

The Scottish Medicines Consortium (SMC) has approved four new medicines for routine use in NHS Scotland.

New results from two phase 3b trials have shown that type 1 and type 2 diabetes patients treated with insulin degludec (Tresiba) experience significantly lower rates of several types of hypoglycaemia, compared with patients treated with insulin glargine U100

A blood test has been developed that can accurately and reliably predict whether depressed patients will respond to common antidepressants.

A 15-year study involving 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men.

A new NHS England-commissioned smartphone app has been launched, which aims to speed up access to care by allowing patients to securely book and/or cancel appointments remotely on their smartphones.

Study results suggest an improvement in overall survival (OS) for patients with ovarian cancer treated with olaparib (Lynparza) maintenance therapy following platinum-based chemotherapy.  

The life chances of many of the 6.5 million people in the UK who care, unpaid, for a disabled, older or ill family member or friend, are being damaged by inadequate support from health services, according to new research launched this week for Carers Week 2016. 

Women diagnosed with migraines have a slightly increased risk of developing cardiovascular diseases, such as heart attacks and strokes, and are more likely to die from these conditions than women who do not have migraine, a large scale study published in The BMJ has revealed.

Women with the most common type of breast cancer could benefit from staying on aromatase inhibitors for a decade, a new study suggests. The study, presented at the American Society of Clinical Oncology (ASCO) conference in Chicago, and published in the New England Journal of Medicine, found that women who took aromatase inhibitors for 10 years rather than five were a third less likely to have their cancer return, or develop cancer in their other breast.